Distribution, OS and PFS for patients in the training cohort based on the SALENTO model and previously proposed risk scores (PIT and IPTCLP)
| . | Score . | N (%) . | 5-year OS (%) (95% CI) . | Log rank . | P value . | HR (95% CI) . | 5-year PFS (%) (95% CI) . | HR (95% CI) . | Log rank . | P value . |
|---|---|---|---|---|---|---|---|---|---|---|
| SALENTO | ||||||||||
| 0 | 55 (26) | 78 (29-127) | 34.4 | < .001 | 1.00 | 66 (33-99) | 1.00 | 36.7 | < .001 | |
| 1 | 86 (41) | 46 (24-68) | 2.2 (1.6-2.9) | 37 (9-65) | 2.3 (1.6-2.9) | |||||
| 2 | 70 (33) | 25 (20-30) | 1.9 (1.5-2.8) | 17 (9-25) | 2.1 (1.5-2.9) | |||||
| PIT | ||||||||||
| 0 | 49 (32) | 79 (27-131) | 29.5 | .001 | 1.00 | 62 (25-99) | 1.00 | 26, 2 | .001 | |
| 1 | 64 (42) | 44 (24-64) | 2.2 (1.4-3.2) | 37 (15-74) | 2.0 (1.5-2.7) | |||||
| 2 | 39 (26) | 22 (19-25) | 2.7 (2.1-3.1) | 16 (14-21) | 2.1 (1.4-2.6) | |||||
| IPTCLP | ||||||||||
| 0 | 20 (10) | 91 (23-159) | 18.2 | .001 | 1.00 | 84 (31-137) | 1.00 | 13.7 | .001 | |
| 1 | 89 (42) | 58 (19-97) | 1.8 (1.1-2.7) | 40 (13-67) | 1.5 (1.1-2.2) | |||||
| 2 | 102 (48) | 32 (14-50) | 2.1 (1.6-3.1) | 28 (15-41) | 1.9 (1.6-2.9) |
| . | Score . | N (%) . | 5-year OS (%) (95% CI) . | Log rank . | P value . | HR (95% CI) . | 5-year PFS (%) (95% CI) . | HR (95% CI) . | Log rank . | P value . |
|---|---|---|---|---|---|---|---|---|---|---|
| SALENTO | ||||||||||
| 0 | 55 (26) | 78 (29-127) | 34.4 | < .001 | 1.00 | 66 (33-99) | 1.00 | 36.7 | < .001 | |
| 1 | 86 (41) | 46 (24-68) | 2.2 (1.6-2.9) | 37 (9-65) | 2.3 (1.6-2.9) | |||||
| 2 | 70 (33) | 25 (20-30) | 1.9 (1.5-2.8) | 17 (9-25) | 2.1 (1.5-2.9) | |||||
| PIT | ||||||||||
| 0 | 49 (32) | 79 (27-131) | 29.5 | .001 | 1.00 | 62 (25-99) | 1.00 | 26, 2 | .001 | |
| 1 | 64 (42) | 44 (24-64) | 2.2 (1.4-3.2) | 37 (15-74) | 2.0 (1.5-2.7) | |||||
| 2 | 39 (26) | 22 (19-25) | 2.7 (2.1-3.1) | 16 (14-21) | 2.1 (1.4-2.6) | |||||
| IPTCLP | ||||||||||
| 0 | 20 (10) | 91 (23-159) | 18.2 | .001 | 1.00 | 84 (31-137) | 1.00 | 13.7 | .001 | |
| 1 | 89 (42) | 58 (19-97) | 1.8 (1.1-2.7) | 40 (13-67) | 1.5 (1.1-2.2) | |||||
| 2 | 102 (48) | 32 (14-50) | 2.1 (1.6-3.1) | 28 (15-41) | 1.9 (1.6-2.9) |